Tasidotin HCl (Genzyme).
Rasila
Kanwaldeep Kaur
KK
The University of New Mexico Cancer Research and Treatment Center, Division of Hematology Oncology, 900 Camino de Salud NE, Albuquerque, NM 87131, USA.
Verschraegen
Claire
C
D000818:Animals; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D006801:Humans; D008870:Microtubules / Q000378:metabolism*; D015394:Molecular Structure; D009369:Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D009842:Oligopeptides / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D013329:Structure-Activity Relationship
D000970:Antineoplastic Agents; D009842:Oligopeptides; C504233:tasidotin